OtoNexus Revenue and Competitors

Seattle, WA USA

Location

#6377

Growjo Ranking

Estimated Revenue & Valuation

  • OtoNexus's estimated annual revenue is currently $2M per year.(i)
  • OtoNexus's estimated revenue per employee is $98,000

Employee Data

  • OtoNexus has 20 Employees.(i)
  • OtoNexus grew their employee count by 18% last year.

OtoNexus's People

NameTitleEmail/Phone
1
VP Product DevelopmentReveal Email/Phone
2
VP MarketingReveal Email/Phone
3
Chief Technology OfficerReveal Email/Phone
4
Co-founder and Chief Science OfficerReveal Email/Phone
5
Chief Product OfficerReveal Email/Phone
6
Co-founder and Chief Medical OfficerReveal Email/Phone
7
Chairman & CEOReveal Email/Phone
8
BioengineerReveal Email/Phone
9
Biomedical EngineerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$15.7M1122%N/AN/A
#2
$1.1M130%N/AN/A
#3
$26.2M174-41%$247.3MN/A
#4
$0.4M6-33%N/AN/A
#5
$7.4M59-31%N/AN/A
#6
$11.8M84-18%$55.5MN/A
#7
$26.2M174-19%$26MN/A
#8
$11.9M850%$26.3MN/A
#9
$2.7M280%N/AN/A
#10
$577.6M29476%N/AN/A
Add Company

What Is OtoNexus?

OtoNexus is developing the world's first medical device to provide objective diagnostic data to instantly and accurately diagnose middle ear infections (Otitis Media) in children and adults. A simple and elegant solution, the device applies a well-known medical technology, ultrasound, in a completely novel way to achieve a key advance in differentiating when and when not to prescribe antibiotics. One-use-per-patient tips create a recurring revenue stream. The device will provide data in seconds and will be easy to use by physicians or non-physician personnel (NPs, PAs). Definitive, objective data identifying both the presence and the type of fluid behind the eardrum will lead to better outcomes and significantly reduced healthcare costs.

keywords:N/A

N/A

Total Funding

20

Number of Employees

$2M

Revenue (est)

18%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.4M200%N/A
#2
$35M20-47%N/A
#3
$2.1M20-58%N/A
#4
$2.7M205%N/A
#5
$2.1M20-9%N/A